1-2 of 2
Charles Sentman
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Safety Data from a First-in-Human Phase 1 Trial of NKG2D Chimeric Antigen Receptor-T Cells in AML/MDS and Multiple Myeloma

Sarah Nikiforow, MD PhD, Lillian Werner, Joana Murad, PhD, Matthew Jacobs, Lauren Johnston, Sarah Patches, Randie White, Heather Daley, Helene Negre, PhD, Jake Reder, PhD, Charles Sentman, PhD, Terri Wade, MS, Adam Schmucker, MS, Frédéric François Lehmann, MD, Sarah Snykers, PhD, Rachel Allen, RN, MPH, Heidi Dipietro, RN, BSN, Kristen Cummings, RN, BSN, Ilene Galinsky, MSN, ANPc, Nikhil C. Munshi, MD, Robert L. Schlossman, MD, Richard M. Stone, MD, Donna S. Neuberg, ScD, Robert J. Soiffer, MD, Glenn Dranoff, MD, Jerome Ritz, MD, Susanne H.C. Baumeister, MD
Journal: Blood
Blood (2016) 128 (22): 4052.
https://doi.org/10.1182/blood.V128.22.4052.4052
Published: 2016
Journal Articles

NKG2D, An NK Cell Activating Receptor on CD8 + T Cells, Plays An Essential Role In Killing Myeloma Cells

Laleh Talebian, PhD, Kenneth Meehan, MD, Megan E Patey, Dawn A Fisher, B.S., Zbigniew Szczepiorkowski, MD, PhD, Marc Ernstoff, Charles Sentman
Journal: Blood
Blood (2010) 116 (21): 2087.
https://doi.org/10.1182/blood.V116.21.2087.2087
Published: 2010